Children’s Wisconsin and UW Health Pause Puberty Blockers, Hormones
Children’s Wisconsin and UW Health have paused gender-reassignment treatments for minors due to federal funding restrictions, raising concerns about negative mental and physical impacts on transgender youth.
MILWAUKEE — Children’s Wisconsin and UW Health have paused gender-reassignment treatments for minors, citing recent federal policy changes that block Medicaid and Medicare funding for such services. The decision affects puberty blockers, hormone therapy, and other treatments for transgender youth, though both systems continue to provide mental-health support.
Children’s Wisconsin cited “escalating legal and federal regulatory risk,” while UW Health said it is pausing medical involvement “due to recent federal actions” but remains committed to being available for LGBTQ+ patients. Health and Human Services Secretary Robert F. Kennedy Jr. defended the federal approach, calling it a measure to prevent “unsafe, irreversible practices” for children.
Advocates warn the pause could harm the mental and physical well-being of transgender youth. Steve Starkey of OutReach LGBTQ+ Community Center said lack of access may worsen suicide risk, and GSAFE’s Susan Neeley noted that stopping puberty blockers or hormone therapy could cause adverse physical effects, compounding stress on vulnerable youth.
Opponents to "gender-affirming care" state, however, that they are protecting children from experimental, permanent procedures they cannot fully consent to. Mental health support remains available without exposing youth to puberty blockers or hormone therapy, ensuring their safety while families and professionals navigate identity and development responsibly.
Previously, the UOJ reported that a Texas doctor who "transitioned" children had to surrender her medical license.
